Advertisement
Australia markets open in 4 hours 56 minutes

  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     

  • AUD/USD

    0.6413
    -0.0032 (-0.49%)
     

  • ASX 200

    7,612.50
    -140.00 (-1.81%)
     

  • OIL

    85.45
    +0.04 (+0.05%)
     

  • GOLD

    2,409.80
    +26.80 (+1.12%)
     

  • Bitcoin AUD

    98,301.46
    +147.64 (+0.15%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Top Ranked Growth Stocks to Buy for June 29th

Zacks Equity Research
·2-min read

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, June 29th:

Bristol-Myers Squibb Company (BMY): This biopharmaceutical products developer carries a Zacks Rank #2 (Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Bristol-Myers Squibb has a PEG ratio of 1.12 compared with 1.88 for the industry. The company possesses a Growth Score of A.

Inphi Corporation (IPHI): This high-speed analog and mixed signal semiconductor solutions provider carries a Zacks Rank #2, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.

ADVERTISEMENT

Inphi has a PEG ratio of 0.13 compared with 5.69 for the industry. The company possesses a Growth Score of A.

Lowe's Companies, Inc. (LOW): This home improvement retailer carries a Zacks Rank #2, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.

Lowe's has a PEG ratio of 1.21 compared with 1.24 for the industry. The company possesses a Growth Score of A.

Parker-Hannifin Corporation (PH): This motion and control technologies and systems manufacturer carries a Zacks Rank #2, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.

Parker-Hannifin has a PEG ratio of 1.51 compared with 9.97 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ParkerHannifin Corporation (PH) : Free Stock Analysis Report
 
Lowes Companies, Inc. (LOW) : Free Stock Analysis Report
 
Inphi Corporation (IPHI) : Free Stock Analysis Report
 
Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research